Skip to main content
. 2013 Jul 26;4(4):86. doi: 10.1186/scrt245

Figure 2.

Figure 2

Therapeutic assessments of the ischemic limbs. (a), (b) Limb quality was evaluated visually according to the degree of necrosis. Gastrocnemius muscle force (c) and mass (d) were determined after 30 days of cell therapy. Is, ischemic group; MSC-Ba, ischemic animals treated with mesenchymal stem cells (MSCs) obtained from BALB/c mice; MSC-Bl, ischemic animals treated with MSCs obtained from C57/BL6 mice; N-IS, nonischemic group; S, sham-operated group. *P <0.05, n = 6 per group.